Compare Danaher Corporation (DHR) vs Unilever plc (UL) Price & Performance

Danaher (DHR) trades at $199.05, showing minimal daily change, with a bullish technical signal supported by moving averages. The company maintains strong profitability with a 58.94% gross margin and has beaten earnings estimates for the last three quarters. Recent news highlights the acquisition of Masimo and new product launches in its SCIEX division, indicating growth initiatives. Cash flow improved in 2025 to a net inflow of $2.54 billion, though revenue growth remains modest.

The outlook is positive with a consensus price target of $211.33, representing a 6% upside, and 69% of analysts rate it a buy. Risks include slowing revenue growth, high valuation multiples, and integration challenges from acquisitions. The stock offers a dividend yield supported by stable cash flows, but investors should monitor competitive pressures in the life sciences sector.

Unilever (UL) trades at $61.48, down 0.39% on the day, with a bullish technical signal driven by moving averages. The company reported $60.76B in 2024 revenue but missed Q1 and Q2 2025 EPS estimates. Recent news highlights strategic moves including a potential bid for Thorne and a $270M innovation center investment. The stock shows strong profitability with a 18.75% net margin and 53.32% ROE, though valuation ratios like P/E of 20.84 suggest fair pricing amid mixed analyst sentiment.

Outlook remains cautious with near-term earnings misses offset by long-term growth initiatives. Investment appeal hinges on successful integration of acquisitions and margin improvement. Key risks include competitive pressures and macroeconomic volatility. Analysts are divided with 24% buy ratings, reflecting balanced risk-reward at current levels.